Prudential Financial Inc Iveric Bio, Inc. Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$26.24 - $39.63 $282,342 - $426,418	-10,760 Reduced 51.41%	10,170 $400,000
Q1 2023 May 12, 2023	SELL	$18.67 - $24.56 $814,852 - $1.07 Million	-43,645 Reduced 67.59%	20,930 $509,000
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $28,480 - $39,565	-1,652 Reduced 2.49%	64,575 $0
Q3 2022 Nov 04, 2022	BUY	$9.4 - $18.59 $622,533 - $1.23 Million	66,227 New	66,227 $1.19 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $1.68 Million - $3.49 Million	-184,410 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.15 - $16.83 $2.24 Million - $3.1 Million	184,410 New	184,410 $3.1 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.